Treatment and prevention of the adverse effects of reactive oxygen species.

摘要

BUCILAMINE AND N-2,2-DIMETHYL-3MERCAPTOPROPIONIL) -L-CYSTEINE OR RELATED COMPOUNDS MAY BE USED TO AVOID DAMAGE TO LIVING FABRICS THAT ARE DERIVED FROM THE FORMATION OR PRESENCE OF REACTIVE OXYGEN SPECIES. THESE REAGENT SPECIES OF OXYGEN ARE FORMED WHEN THE TISSUE IS RETURNED FOR THE FIRST TIME HYPOXIC DUE TO THE INTERRUPTION OF THE BLOOD FLOW AND THEN REOXIGATES THROUGH THE RESTORATION OF THE BLOOD FLOW. IN PARTICULAR THE INVENTION REFERS TO THE ADMINISTRATION OF BUCILAMINE AND N-2,2-DIMETHYL-3MERCAPTOPROPIONIL) -L-CISTEINE BEFORE OR COINCIDING WITH THE REPERFUSION TO AVOID DAMAGE TO THE MIOCARDY THAT IS DERIVED FROM THE REACTION OF SPECIFICATION. APPLICATIONS OF THESE COMPOUNDS FOR SIMILAR CELL INJURIES RELATED TO THE ISCHEMIA OR OTHER ORGANS ARE ALSO SUBMITTED.